Anderson Glen R. 13D and 13G filings for Indaptus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-16 5:57 pm Purchase |
2023-08-14 | 13G | Indaptus Therapeutics, Inc. INDP |
Anderson Glen R. | 42,514 14.170% |
3,691 (+9.51%) |
Filing |
| 2022-07-07 7:40 pm Purchase |
2022-06-27 | 13G | Indaptus Therapeutics, Inc. INDP |
Anderson Glen R. | 38,823 13.160% |
12,463 (+47.28%) |
Filing |
| 2021-11-17 09:00 am Purchase |
2021-09-29 | 13D | Indaptus Therapeutics, Inc. INDP |
Anderson Glen R. | 26,360 9.000% |
7,495 (+39.73%) |
Filing |
| 2021-10-26 5:16 pm Purchase |
2021-09-29 | 13D | Indaptus Therapeutics, Inc. INDP |
Anderson Glen R. | 18,866 6.400% |
4,133 (+28.05%) |
Filing |
| 2021-08-19 4:05 pm Purchase |
2021-08-03 | 13D | Indaptus Therapeutics, Inc. INDP |
Anderson Glen R. | 14,733 7.600% |
14,733 (New Position) |
Filing |